Breaking News
Subscribe Now 0
🧐 ProPicks AI October update is out now! See which stocks made the list Pick Stocks with AI
Close

Chugai Pharmaceutical Co., Ltd. (4519)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
42.5800 +0.6700    +1.60%
04/10 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  JP3519400000 
S/N:  857216
  • Volume: 1
  • Bid/Ask: 42.3500 / 43.6500
  • Day's Range: 40.3100 - 42.5800
Chugai Pharmaceutical 42.5800 +0.6700 +1.60%

Chugai Pharmaceutical Co Ltd Company Profile

 
Get an in-depth profile of Chugai Pharmaceutical Co., Ltd., including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

7771

Equity Type

ORD

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances and collaboration with Roche Group. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd.

Contact Information

Address 2-1-1 Nihonbashi-Muromachi
Chuo, 103-8324
Japan
Phone 81 3 3281 6611
Fax 81 3 3281 6607

Top Executives

Name Age Since Title
Osamu Nagayama 75 1989 Honorary Chairman & Senior Advisor
Iwaaki Taniguchi 57 2022 Executive VP, Head of Finance Supervisory Division, CFO & Director
Andre S. Hoffmann 66 - Member of the International Advisory Council
Victor Halberstadt - - Member of the International Advisory Council
Franz Bernhard Humer 78 2014 Member of the International Advisory Council
William A. M. Burns 77 - Member of the International Advisory Council
Andrew C. von Eschenbach 82 - Member of the International Advisory Council
Henry L. Nordhoff 82 - Chairman of the International Advisory Council
Osamu Okuda 61 2014 President, CEO & Chairman
Yoshiaki Ohashi 64 2015 Senior VP & Full-time Audit Supervisory Board Member
Sonosuke Kadonaga 72 - Member of the International Advisory Council
Christoph Franz 64 2017 Non-Executive Director
Hitoshi Iikura 54 2024 Executive VP, Head of Translational Research Division & Director
Fumio Tateishi 75 2023 Outside Independent Director
Teresa A. Graham 51 2023 Non-Executive Director
Shigehiro Yamada 60 2019 Full-Time Audit & Supervisory Board Member
Kenichi Masuda 61 2020 Outside Independent Audit & Supervisory Board Member
Mariko Y. Momoi 76 2020 Outside Independent Director
Yumiko Waseda 64 2023 Outside Independent Audit & Supervisory Board Member
Hideo Teramoto 64 2023 Outside Independent Director
Mami Yunoki 61 2024 Outside Independent Audit & Supervisory Board Member
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4519 Comments

Write your thoughts about Chugai Pharmaceutical Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email